We invite investigators to apply for funding through our biomedical technology optimization and dissemination (BTOD) program (PAR-23-110). This initiative supports the creation of BTOD centers dedicated to optimizing and broadly disseminating state-of-the-art, mission-relevant, late-stage technologies to both experts and nonexperts in biomedical research.

BTOD centers are built around three tightly integrated components (refer to diagram):

• Technology optimization projects
• Driving biomedical projects
• Community engagement

We’ve reissued two notices of funding opportunities (NOFOs) for our Technology Development Programs:

Technology Development Research for Establishing Feasibility and Proof of Concept (R21 Clinical Trial Not Allowed) PAR-25-202

This NOFO solicits R21 applications with innovative, high-risk concepts for developing new technologies or radically improving existing ones. It supports novel concepts that haven’t been tested for feasibility. Because inclusion of unpublished or preliminary data isn’t allowed under this NOFO, NIGMS expects the proposed projects to be high risk.  

Saad Bhamla, Ph.D. Credit: Rob Felt, Georgia Tech.

What does a children’s toy have to do with malaria diagnostics? How about a barbecue lighter and a nucleic acid vaccine? Find out from Saad Bhamla during our 2024 Judith H. Greenberg Early Career Investigator Lecture. The lecture, “Fast and Frugal: Cells That Move Without ATP and Life-Saving Tools That Cost Pennies,” will take place on October 7 at 1:00 p.m. ET.

UPDATE: The video for this webinar is now available.

Are you interested in submitting a grant application for the Biomedical Technology Optimization and Dissemination Center (BTOD) program (PAR-23-110)? If so, please join our informational webinar to learn more about the program and application components and to ask questions:

Wednesday, September 27, 4:00-5:30 p.m. ET 
Zoom meeting registration link

UPDATE: The webinar videois now available.

We’re pleased to share the notice of funding opportunity (NOFO) for our biomedical technology optimization and dissemination (BTOD) centers (RM1) (PAR-23-110). The goals of the BTOD centers are to optimize state-of-the-art, NIGMS mission-relevant, late-stage technologies, and to disseminate these technologies to both experts and nonexperts in biomedical research for their broad use. A BTOD center may focus on optimizing a single technology or multiple integrated technologies. Community engagement activities should result in broad dissemination of the optimized technologies for the research community’s sustainable use.

UPDATE: The video for this webinar is now available.

We’re pleased to share that NIGMS has reissued two funding opportunity announcements (FOAs) for our technology development program. Both FOAs support the development of novel technologies with the potential for broad utility in biomedical research. They are:

Technology Development Research for Establishing Feasibility and Proof of Concept (R21)
PAR-22-126

Applications to this FOA should propose technology development at a conceptual stage, not yet supported by any proof-of-concept-data, in order to demonstrate feasibility of the proposed technology and/or establish the most likely path to successful development. When compared to current state-of-the-art technology, the proposed concept should lead to a technological breakthrough or a significant advance in current biomedical research or approaches.

First application receipt date: June 16